Severe and critical SARS-COV-2 delta variant infection in infants without underlying medical conditions

Aida Borgi1, Assaad Louati1, Amal Miraoui1

  • 1Paediatric Intensive Care Unit Children's Hospital of Tunis Tunis Tunisia.

Insights

The SARS-CoV-2 Delta variant caused severe respiratory illness in infants without comorbidities. This study highlights the critical impact of COVID-19 on vulnerable infants.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The SARS-CoV-2 Delta variant emerged as a significant global health threat.
  • Infants, particularly those without comorbidities, were assessed for severe COVID-19 outcomes.

Observation:

  • A case series of 20 infants under 15 years admitted to the Pediatric Intensive Care Unit (PICU) during the Delta variant surge.
  • Median age was 47 days; no infants had prior medical conditions.
  • Parental vaccination status was unknown, but they were unvaccinated.

Findings:

  • Respiratory involvement was the primary clinical manifestation, with 11 patients experiencing pediatric acute respiratory distress (PARDS).
  • Four patients exhibited hemodynamic instability.
  • Radiological findings included ground-glass opacities in 11 cases.
  • Seventeen patients required mechanical ventilation, with 3 escalated to high-frequency oscillatory ventilation.
  • Four patients (20%) died.

Implications:

  • The SARS-CoV-2 Delta variant poses a severe risk to previously healthy infants.
  • Prompt recognition and intensive care are crucial for managing severe COVID-19 in this population.
  • Further research into infant-specific COVID-19 responses and preventative strategies is warranted.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
336
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
301
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
298
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
191
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
419